Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

Clinical trial NCT05315258 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05315258
Sponsor: University of Oxford
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)Melanoma, Uveal

Start date: 2022-07-25
Primary completion: 2026-12-30
Enrollment: 850

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.